Search Results - "Oki, Eishin"

Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan; 2nd report QOL survey by Shiraishi, Hideaki, Yamada, Kenji, Oki, Eishin, Ishige, Mika, Fukao, Toshiyuki, Hamada, Yusuke, Sakai, Norio, Ochi, Fumihiro, Watanabe, Asami, Kawakami, Sanae, Kuzume, Kazuyo, Watanabe, Kenji, Sameshima, Koji, Nakamagoe, Kiyotaka, Tamaoka, Akira, Asahina, Naoko, Yokoshiki, Saki, Miyakoshi, Takashi, Oba, Koji, Isoe, Toshiyuki, Hayashi, Hiroshi, Yamaguchi, Seiji, Sato, Norihiro

“…Fatty acid oxidation disorders (FAODs) are rare diseases caused by a defective mitochondrial fatty acid oxidation (FAO) enzyme. We recently reported that…”
Get full text

Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan by Yamada, Kenji, Shiraishi, Hideaki, Oki, Eishin, Ishige, Mika, Fukao, Toshiyuki, Hamada, Yusuke, Sakai, Norio, Ochi, Fumihiro, Watanabe, Asami, Kawakami, Sanae, Kuzume, Kazuyo, Watanabe, Kenji, Sameshima, Koji, Nakamagoe, Kiyotaka, Tamaoka, Akira, Asahina, Naoko, Yokoshiki, Saki, Miyakoshi, Takashi, Ono, Kota, Oba, Koji, Isoe, Toshiyuki, Hayashi, Hiroshi, Yamaguchi, Seiji, Sato, Norihiro

“…Fatty acid oxidation disorders (FAODs) are rare diseases caused by defects in mitochondrial fatty acid oxidation (FAO) enzymes. While the efficacy of…”
Get full text

Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients by Tanaka, Hiroshi, Tsugawa, Koji, Oki, Eishin, Suzuki, Koichi, Ito, Etsuro

“…The objective of the current work is to report our preliminary experience with the mizoribine (MZR) intermittent pulse protocol for induction therapy for newly…”
Get full text

Benefits of Once-Daily Administration of Cyclosporine A for Children with Steroid-Dependent, Relapsing Nephrotic Syndrome by Suzuki, Koichi, Oki, Eishin, Tsuruga, Kazushi, Aizawa-Yashiro, Tomomi, Ito, Etsuro, Tanaka, Hiroshi

“…Cyclosporine A (CsA) is an effective steroid-sparing agent for patients with steroid-dependent, relapsing nephrotic syndrome (SDRNS). The efficacy and safety…”
Get full text

Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis by Tsugawa, Koji, Oki, Eishin, Suzuki, Koichi, Imaizumi, Tadaatsu, Ito, Etsuro, Tanaka, Hiroshi

“…Recent studies have suggested that gene expression studies using urinary sediment might be a non-invasive approach to assessing activity and pathogenesis in…”
Get full text

Leukocytapheresis for the treatment of refractory Henoch–Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy by Oki, Eishin, Tsugawa, Koji, Suzuki, Koichi, Ito, Etsuro, Tanaka, Hiroshi

“…Henoch–Schönlein purpura (HSP) is a childhood disorder, which is the vasculitis of systemic small vessels of unknown etiology. We encountered the dramatic…”
Get full text

A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis by Oki, Eishin, Tsuruga, Kazushi, Kudo, Masanobu, Tsugawa, Koji, Suzuki, Koichi, Tanaka, Hiroshi

Get full text

Dense deposit disease presenting as endocapillary proliferative nephritis by Suzuki, Koichi, Tsugawa, Koji, Oki, Eishin, Aita, Kumi, Endo, Morito, Waga, Shinobu, Ito, Etsuro, Tanaka, Hiroshi

Get full text

Early initiation of peritoneal dialysis for the treatment of a patient with refractory nephrotic syndrome by Tsuruga, Kazushi, Oki, Eishin, Suzuki, Kouichi, Takahashi, Yoshihiro, Tanaka, Hiroshi

“…A proportion of patients with refractory nephrotic syndrome (NS) due to focal segmental glomerulosclerosis (FSGS) often require long-term hospitalization,…”
Get more information

Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus by OKI, Eishin, TSUGAWA, Koji, SUZUKI, Koichi, TANAKA, Hiroshi

“…It has been reported that aggressive immunosuppressive treatment is effective for controlling the disease activity of refractory systemic lupus erythematosus…”
Get full text

Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation by Tanaka, Tatsuhiko, Oki, Eishin, Mori, Takayasu, Tsuruga, Kazushi, Sohara, Eisei, Uchida, Shinichi, Tanaka, Hiroshi

Get full text

Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice by Tanaka, Hiroshi, Watanabe, Shojiro, Aizawa-Yashiro, Tomomi, Oki, Eishin, Kumagai, Naonori, Tsuruga, Kazushi, Ito, Etsuro

“…The optimal long-term treatment for lupus nephritis (LN) in pubertal patients remains to be determined. Tacrolimus (Tac) inhibits T cell activation, and is…”
Get more information

Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome by Aizawa-Yashiro, Tomomi, Tsuruga, Kazushi, Watanabe, Shojiro, Oki, Eishin, Ito, Etsuro, Tanaka, Hiroshi

“…An effective treatment for children with refractory nephrotic syndrome (NS), especially in those with cyclosporine (CsA)-resistant or CsA-intolerant NS, has…”
Get full text

Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells by Imaizumi, Tadaatsu, Tanaka, Hiroshi, Matsumiya, Tomoh, Yoshida, Hidemi, Tanji, Kunikazu, Tsuruga, Kazushi, Oki, Eishin, Aizawa-Yashiro, Tomomi, Ito, Etsuro, Satoh, Kei

“…Background. Retinoic acid-inducible gene-I (RIG-I) is a putative RNA helicase involved in immune reactions against RNA viruses and various inflammatory and…”
Get full text

Imbalance towards Th1 pathway predominance in purpura nephritis with proteinuria by Tsuruga, Kazushi, Watanabe, Shojiro, Oki, Eishin, Aizawa-Yashiro, Tomomi, Yoshida, Hidemi, Imaizumi, Tadaatsu, Ito, Etsuro, Tanaka, Hiroshi

“…Although recent reports suggest a possible role for an imbalance in Th1 and Th2 proinflammatory cytokines in the development and progression of…”
Get full text

Potential Th1/Th2 predominance in children with newly diagnosed IgA nephropathy by Tsuruga, Kazushi, Oki, Eishin, Aizawa-Yashiro, Tomomi, Yoshida, Hidemi, Imaizumi, Tadaatsu, Tanaka, Hiroshi

Get full text

Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy by Aizawa-Yashiro, Tomomi, Oki, Eishin, Tsuruga, Kazushi, Nakahata, Tohru, Ito, Etsuro, Tanaka, Hiroshi

“…A 7-year-old Japanese boy with a 4-month history of systemic juvenile idiopathic arthritis (s-JIA) experienced disease flare with spiking fever, exanthema and…”
Get full text

Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis by Tanaka, Hiroshi, Oki, Eishin, Tsuruga, Kazushi, Aizawa-Yashiro, Tomomi, Ito, Yuya, Sato, Norihiro, Kawasaki, Yukihiko, Suzuki, Junzo

“…The purine synthesis inhibitor mizoribine (MZR) has been successfully used without serious adverse effects in the treatment of several renal diseases including…”
Get full text

Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome by Tsuruga, Kazushi, Oki, Eishin, Yashiro, Tomomi, Ito, Etsuro, Tanaka, Hiroshi

Get full text

Vesical varices and telangiectasias in a patient with ataxia telangiectasia by Suzuki, Koichi, Tsugawa, Koji, Oki, Eishin, Morio, Tomohiro, Ito, Etsuro, Tanaka, Hiroshi

“…A Japanese boy with ataxia telangiectasia (AT) developed severe gross hematuria and recurrent bladder tamponade, requiring an extensive blood transfusion. He…”
Get full text